• Product NameCapecitabine
• Brief DescriptionInhibitors
• Purification99.89%
• Biological ActivityProdrug of 5-Fluorouracil (5-FU). Selectively activated in tumor cells by thymidine phosphorylase; inhibits DNA synthesis upon conversion to 5-FU. Orally available.
• Target NameDNA/RNA Synthesis inhibitor
• CAS No. 154361-50-9
• Calculated MW 359.35
• Formulation C15H22FN3O6
• Storage 3 years -20˚C powder;2 years -80˚C in solvent;

• Research Area:Cancer
  SMILES:CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O
  Pathways:DNA Damage/DNA Repair
  Receptor:Thymidine phosphorylase
  Boling pt:
  Melting pt:110-121C
  Solubility:Ethanol: 72 mg/mL (200.36 mM); Water: 6 mg/mL (16.69 mM); DMSO: 72 mg/mL (200.36 mM)
  Appearance:White Powder
  Remark:For obtaining a higher solubility , please warm the tube at 37 ˚C and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ˚C for several month.

1. Lv H, et al. Chin J Y Res. 2014 Dec; 26(6):692-7.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting